- Home
- TECX vs DDI Comparison
TECX vs DDI Comparison
Compare TECX & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- DDI
- Stock Information
- Founded
- TECX 2019
- DDI 2008
- Country
- TECX United States
- DDI South Korea
- Employees
- TECX N/A
- DDI N/A
- Industry
- TECX
- DDI EDP Services
- Sector
- TECX
- DDI Technology
- Exchange
- TECX Nasdaq
- DDI Nasdaq
- Market Cap
- TECX 387.1M
- DDI 444.0M
- IPO Year
- TECX 2018
- DDI 2021
- Fundamental
- Price
- TECX $19.02
- DDI $8.77
- Analyst Decision
- TECX Buy
- DDI Strong Buy
- Analyst Count
- TECX 6
- DDI 5
- Target Price
- TECX $79.17
- DDI $19.60
- AVG Volume (30 Days)
- TECX 515.4K
- DDI 39.0K
- Earning Date
- TECX 11-06-2025
- DDI 11-10-2025
- Dividend Yield
- TECX N/A
- DDI N/A
- EPS Growth
- TECX N/A
- DDI N/A
- EPS
- TECX N/A
- DDI 2.15
- Revenue
- TECX N/A
- DDI $333,256,000.00
- Revenue This Year
- TECX N/A
- DDI $16.04
- Revenue Next Year
- TECX N/A
- DDI $6.72
- P/E Ratio
- TECX N/A
- DDI $4.09
- Revenue Growth
- TECX N/A
- DDI 0.24
- 52 Week Low
- TECX $13.70
- DDI $8.09
- 52 Week High
- TECX $61.07
- DDI $18.21
- Technical
- Relative Strength Index (RSI)
- TECX 61.68
- DDI 35.21
- Support Level
- TECX $16.98
- DDI $8.72
- Resistance Level
- TECX $18.77
- DDI $9.09
- Average True Range (ATR)
- TECX 1.30
- DDI 0.21
- MACD
- TECX 0.54
- DDI -0.03
- Stochastic Oscillator
- TECX 96.12
- DDI 6.85
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.